Valtech Cardio

Valtech Cardio was a medical device company based in Or Yehuda, Israel, focused on developing advanced technologies for treating mitral and tricuspid heart valve diseases. The company specialized in creating innovative transcatheter repair systems, with its core product being the Cardioband System. This system offers a minimally invasive approach to valve repair, providing an alternative to traditional open-heart surgery for patients with valve regurgitation. The Cardioband System is a transcatheter mitral annuloplasty device that helps reduce mitral valve regurgitation by cinching the valve annulus, improving valve function and patient outcomes. Valtech Cardio primarily served hospitals, cardiology centers, and healthcare providers specializing in structural heart disease treatment. In January 2017, Valtech Cardio was acquired by Edwards Lifesciences Corporation, enhancing Edwards' portfolio in transcatheter valve repair therapies and expanding the use of the Cardioband technology, particularly in Europe.

• Employees 5
• Founded 2005
• Annual Revenue $3000000
• Total Funding $24300000